Sarcopenia in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review of the Literature.

Bertschi, D.; Kiss, C M; Schoenenberger, A. W.; Stuck, A. E.; Kressig, R W (2021). Sarcopenia in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review of the Literature. Journal of nutrition, health & aging, 25(1), pp. 64-70. Springer 10.1007/s12603-020-1448-7

[img] Text
Bertschi2021_Article_SarcopeniaInPatientsUndergoing.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (460kB) | Request a copy

BACKGROUND

In older patients, sarcopenia is a prevalent disease associated with negative outcomes. Sarcopenia has been investigated in patients undergoing transcatheter aortic valve implantation (TAVI), but the criteria for diagnosis of the disease are heterogeneous. This systematic review of the current literature aims to evaluate the prevalence of sarcopenia in patients undergoing TAVI and to analyse the impact of sarcopenia on clinical outcomes.

METHODS

A comprehensive search of the literature has been performed in electronic databases from the date of initiation until March 2020. Using a pre-defined search strategy, we identified studies assessing skeletal muscle mass, muscle quality and muscle function as measures for sarcopenia in patients undergoing TAVI. We evaluated how sarcopenia affects the outcomes mortality at ≥1 year, prolonged length of hospital stay, and functional decline.

RESULTS

We identified 18 observational studies, enrolling a total number of 9'513 patients. For assessment of skeletal muscle mass, all included studies used data from computed tomography. Cut-off points for definition of low muscle mass were heterogeneous, and prevalence of sarcopenia varied between 21.0% and 70.2%. In uni- or multivariate regression analysis of different studies, low muscle mass was found to be a significant predictor of mortality, prolonged length of hospital stay, and functional decline. No interventional study was identified measuring the effect of nutritional or physiotherapy interventions on sarcopenia in TAVI patients.

CONCLUSIONS

Sarcopenia is highly prevalent among patients undergoing TAVI, and negatively affects important outcomes. Early diagnosis of this condition might allow a timely start of nutritional and physiotherapy interventions to prevent negative outcomes in TAVI patients.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Geriatric Clinic

UniBE Contributor:

Bertschi, Dominic; Schoenenberger, Andreas and Stuck, Andreas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1279-7707

Publisher:

Springer

Language:

English

Submitter:

Rebecca Rufer

Date Deposited:

26 Jul 2021 09:26

Last Modified:

26 Jul 2021 09:51

Publisher DOI:

10.1007/s12603-020-1448-7

PubMed ID:

33367464

Uncontrolled Keywords:

Sarcopenia aortic valve replacement cardiology geriatrics malnutrition

BORIS DOI:

10.48350/157615

URI:

https://boris.unibe.ch/id/eprint/157615

Actions (login required)

Edit item Edit item
Provide Feedback